Dilip Shanghvi ousts Mukesh Ambani as the richest man in India
This happened soon after the shares of
According to an ET report, this sudden gain was a result of the US Food and Drug Administration’s (FDA’s) approval that SPARC received in order to manufacture a product at Sun's facility in Halol.
On Wednesday, Shanghvi's networth stood at $21.5 billion while Ambani’s was $20.4 billion.
Earlier on Tuesday, Sun Pharma announced it will buy out